Janux Therapeutics vs Umlaut.bio
Janux Therapeutics vs Umlaut.bio, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Janux Therapeutics is on 57/100 and Umlaut.bio on 35/100.
Where each one leads
Janux Therapeutics
- our overall score: 57/100 against 35/100
- agent readiness: 42/100 against 37/100
- domain rating: 39/100 against 7/100
- funding raised: $181M against $3.0M
Umlaut.bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Janux Therapeutics | Umlaut.bio |
|---|---|---|
| What it is | A clinical-stage biopharmaceutical company developing novel immunotherapies. | Developing novel immunotherapies for cancer. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy | Biotechnology, Cancer, Immunotherapy, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2022 |
| Headquarters | San Diego, USA | Cambridge, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Janux Therapeutics | Umlaut.bio |
|---|---|---|
| Employees | 110 | Not published |
| Total funding | $181M | $3.0M |
| Latest round | Series B | Pre-Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 12,449 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Janux Therapeutics | Umlaut.bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 35/100 |
| Traction | 60/100 | 32/100 |
| Team | 30/100 | Not published |
| Search visibility | 35/100 | 8/100 |
| Quality | 68/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 39/100 | 7/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Janux Therapeutics | Umlaut.bio |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Janux Therapeutics vs Umlaut.bio: common questions
Which is better, Janux Therapeutics or Umlaut.bio?
On our 0-100 score Janux Therapeutics rates higher (57/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Janux Therapeutics and Umlaut.bio compare on the numbers?
Janux Therapeutics leads on our overall score (57/100 against 35/100), agent readiness (42/100 against 37/100), domain rating (39/100 against 7/100), funding raised ($181M against $3.0M).
Read the full Janux Therapeutics review and pricing or the Umlaut.bio review and pricing. You can also browse other Janux Therapeutics alternatives we track.